This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany



RIBOPRO is an innovative and fast-growing mRNA specialist, providing premium (m)RNA technology, formulation and CDMO services to the pharmaceutical and biotechnology industry. RIBOPRO designs and synthesises high-performance mRNA for R&D and GMP purposes and delivers unconditional support from early research into clinical trials and commercialization.

Through their in-house research, the company continuously develops both the manufacturing processes for high quality mRNA and lipid nanoparticles (LNPs) and develops novel technologies to boost the performance of the mRNA/gain control over the delivery. These technologies not only provide better outcomes, but also provide freedom to operate in an otherwise competitive marketplace.